文献速递肝胆胰外科

吲哚菁绿荧光成像在腹腔镜保留实质肝切除治疗神经内分泌肿瘤肝转移中的切缘评估与无复发生存作用

Role of indocyanine green fluorescence imaging in margin assessment and recurrence-free survival in laparoscopic parenchyma-sparing hepatectomy for neuroendocrine tumor liver metastases.
PubMed 文献 · Surg Endosc · 2025-01-06

本研究回顾性纳入51例接受腹腔镜保留实质肝切除术的神经内分泌肿瘤肝转移患者,比较ICG荧光成像组与非ICG组的围手术期结局和無復發生存。ICG组病理阳性切缘显著更低(1.3% vs. 16.4%,p < 0.001),中位无复发生存期在ICG组更长但差异未达统计学显著(38.0 vs. 29.0个月,p = 0.086)。结论认为ICG可能改善手术切缘并潜在提升无复发生存。

要点

  • ICG荧光成像可显著降低神经内分泌肿瘤肝转移患者腹腔镜保留实质肝切除术后的病理阳性切缘率。
  • ICG组中位无复发生存期较非ICG组长,但差异未达统计学显著。
  • 术后并发症发生率为52.9%,以胆漏最常见,无围手术期死亡。

核心结论

  • ICG荧光成像用于腹腔镜保留实质肝切除可能改善神经内分泌肿瘤肝转移患者的手术切缘并潜在提升无复发生存。

研究设计与样本

  • 单中心回顾性队列研究,纳入2013年8月至2023年5月接受腹腔镜保留实质肝切除的神经内分泌肿瘤肝转移患者共51例。

主要发现

  • ICG组与非ICG组基线特征无显著差异。
  • 术后并发症发生率为52.9%,胆漏最常见,无围手术期死亡。
  • ICG组病理阳性切缘显著低于非ICG组(1.3% vs. 16.4%,p < 0.001)。
  • 中位随访36个月,62.7%患者复发,多为肝内复发。
  • ICG组中位无复发生存期较非ICG组长但无统计学显著差异(38.0 vs. 29.0个月,p = 0.086)。

临床怎么用

  • 在腹腔镜保留实质肝切除治疗神经内分泌肿瘤肝转移时,可考虑使用ICG荧光成像辅助切缘评估以降低阳性切缘率。

局限性

  • 本研究为单中心回顾性队列研究,样本量较小(51例),需更大规模前瞻性研究确认ICG对长期预后的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuroendocrine liver metastases (NELM) significantly reduce survival in patients with neuroendocrine tumor. The management of NELM is challenged by a low rate of resectability and a high rate of recurrence. Indocyanine green (ICG) fluorescence imaging offers potential advantages in real-time tumor visualization and margin assessment. This study evaluates the impact of ICG fluorescence on perioperative outcomes and recurrence-free survival (RFS) in NELM patients undergoing laparoscopic parenchyma-sparing hepatectomy (LPSH). METHODS: A retrospective cohort study was performed on patients with NELM who underwent LPSH from August 2013 to May 2023 at our single center. Data on sociodemographic characteristics, laboratory parameters, surgical results and follow-up outcomes were collected. RESULTS: A total of 51 NELM patients were included. No significant differences in baseline characteristics were observed between the ICG and non-ICG groups. Postoperative complications occurred in 52.9% of patients, with bile leakage being most common. No perioperative mortality was reported. Pathologically positive margins were significantly lower in the ICG group (1.3 vs. 16.4%, p < 0.001). After a median follow-up of 36 months, 62.7% of patients experienced recurrence, mostly intrahepatic. Median recurrence-free survival (RFS) was longer in the ICG group, though not statistically significant (38.0 vs. 29.0 months, p = 0.086). CONCLUSION: The use of ICG fluorescence imaging in LPSH may improve surgical margins and potentially enhance RFS in NELM patients. These findings are clinically significant, highlighting the need for larger prospective studies to confirm its impact on long-term prognosis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wang G, Liu C, Qi W, et al. Role of indocyanine green fluorescence imaging in margin assessment and recurrence-free survival in laparoscopic parenchyma-sparing hepatectomy for neuroendocrine tumor liver metastases. Surg Endosc. 2025. PMID: 39762608. doi:10.1007/s00464-024-11508-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。